Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02613923 · ClinicalTrials.gov registry record · NA
A Sleep Intervention to Improve Outcomes Among Women at High Risk of Breast Cancer
A NA study, sponsored by Case Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT02613923: Completed NA study, sponsored by Case Comprehensive Cancer Center.
NCT02613923 is a NA study that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 17 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02613923, a NA study, has completed, sponsored by Case Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
Participants are asked to participate in a research study of the effect of a sleep intervention on improving sleep habits and reducing their risk of breast cancer. Participants are asked to participate in this research study because they have been identified as being at higher than average risk of developing breast cancer. The purpose of this study is to compare women who get a sleep intervention to women who do not get a sleep intervention. This study team will compare these two groups of women to see if the sleep intervention improves their sleep and if it lowers markers of inflammation that have been associated with an increased risk of breast cancer.
Primary Outcome
Sleep quality will be measured by the PSQI which is a continuous measure from 0 (best) to 21 (worst)
Interventions
- PROCEDURE Blood Draw
- BEHAVIORAL GO! To Sleep
- BEHAVIORAL Sleep information
- OTHER Pittsburgh Sleep Quality Index (PSQI)
- OTHER Insomnia Severity Index (ISI)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2015-08-04 |
| Est. Completion | 2017-07-23 |
| Phase | NA |
What the finished NCT02613923 record still lists
NCT02613923 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 5 interventions - of which Blood Draw is the first listed.
NCT02613923 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02613923 about?
NCT02613923 is a clinical study titled "A Sleep Intervention to Improve Outcomes Among Women at High Risk of Breast Cancer". Participants are asked to participate in a research study of the effect of a sleep intervention on improving sleep habits and reducing their risk of breast cancer. Participants are asked to participate in this research study because they have been identified as being at higher than average risk of ...
What is the current status of trial NCT02613923?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2015-08-04. Estimated completion is 2017-07-23.
What interventions are being tested in trial NCT02613923?
The interventions under investigation include: Blood Draw (PROCEDURE), GO! To Sleep (BEHAVIORAL), Sleep information (BEHAVIORAL), Pittsburgh Sleep Quality Index (PSQI) (OTHER), Insomnia Severity Index (ISI) (OTHER).
Who is sponsoring clinical trial NCT02613923?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02613923's enrollment target sits among peer trials
17 1871st of 2000 higher than 130 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI